Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature

Background. Recently antiangiogenic therapy with bevacizumab has shown a high but transient efficacy in glioblastoma (GBM). Indeed, GBM is one of the most angiogenic human tumors and endothelial proliferation is a hallmark of the disease. We therefore hypothesized that tumor cells may participate in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: El Hallani, Soufiane, Colin, Carole, El Houfi, Younas, Idbaih, Ahmed, Boisselier, Blandine, Marie, Yannick, Ravassard, Philippe, Labussière, Marianne, Mokhtari, Karima, Thomas, Jean-Léon, Delattre, Jean-Yves, Eichmann, Anne, Sanson, Marc
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4017715/
https://ncbi.nlm.nih.gov/pubmed/24868550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/827327
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi